Skip to main content
Advertisement
Advertisement

RCUS

RCUS logo

Arcus Biosciences, Inc.

24.41
USD
Sponsored
+0.58
+2.43%
Oct 09, 15:59 UTC -4
Closed
exchange

After-Market

24.41

0.00
-0.02%

RCUS Earnings Reports

Positive Surprise Ratio

RCUS beat 19 of 34 last estimates.

56%

Next Report

Date of Next Report
Oct 26, 2026
Estimate for Q3 26 (Revenue/ EPS)
$11.90M
/
-$0.89
Implied change from Q2 26 (Revenue/ EPS)
-70.97%
/
+23.61%
Implied change from Q3 25 (Revenue/ EPS)
-54.22%
/
-29.92%

Arcus Biosciences, Inc. earnings per share and revenue

On Aug 05, 2026, RCUS reported earnings of -0.72 USD per share (EPS) for Q2 26, beating the estimate of -0.91 USD, resulting in a 21.41% surprise. Revenue reached 41.00 million, compared to an expected 23.87 million, with a 71.74% difference. The market reacted with a +2.27% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 7 analysts forecast an EPS of -0.89 USD, with revenue projected to reach 11.90 million USD, implying an increase of 23.61% EPS, and decrease of -70.97% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Inventiva S.A. - ADR
Report Date
Sep 28, 2026 For Q2 26
Estimate
-$0.37
Actual
-$0.25
Surprise
+33.55%
logo
Palatin Technologies, Inc. Common Stock
Report Date
Sep 28, 2026 For Q4 26
Estimate
-$1.21
Actual
-$1.11
Surprise
+8.42%
FAQ
For Q2 2026, Arcus Biosciences, Inc. reported EPS of -$0.72, beating estimates by 21.41%, and revenue of $41.00M, 71.74% above expectations.
The stock price moved up 2.27%, changed from $27.70 before the earnings release to $28.33 the day after.
The next earning report is scheduled for Oct 26, 2026.
Based on 7 analysts, Arcus Biosciences, Inc. is expected to report EPS of -$0.89 and revenue of $11.90M for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement